Showing results (411-420 of 491) with videos related to

Sort By:
Pageof 50
Journal of the American College of Cardiology|March 19, 2016
Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS TrialRenato D Lopes, Sergio Leonardi, Benjamin Neely, et al.
Plos One|January 26, 2018
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillationJean-Pierre Bassand, Gabriele Accetta, Wael Al Mahmeed, et al.
Journal of the American Heart Association|March 10, 2016
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AFSean D Pokorney, Jonathan P Piccini, Susanna R Stevens, et al.
Clinical Cardiology|August 19, 2023
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registriesToon Wei Lim, Alan John Camm, Saverio Virdone, et al.
Heart (British Cardiac Society)|February 17, 2021
Comparative effectiveness of oral anticoagulants in everyday practiceA John Camm, Keith A A Fox, Saverio Virdone, et al.
Clinical Cardiology|July 29, 2016
Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS TrialLarry R Jackson, Jonathan P Piccini, Derek D Cyr, et al.
The New England Journal of Medicine|November 15, 2011
Rivaroxaban in patients with a recent acute coronary syndromeJessica L Mega, Eugene Braunwald, Stephen D Wiviott, et al.
Circulation|May 28, 2009
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial, John H Alexander, Richard C Becker, et al.
The New England Journal of Medicine|May 22, 2009
Early versus delayed invasive intervention in acute coronary syndromesShamir R Mehta, Christopher B Granger, William E Boden, et al.
JAMA|September 1, 2004
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trialJames A de Lemos, Michael A Blazing, Stephen D Wiviott, et al.
Pageof 50